Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp J Hohensinner

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Vascular Pharmacology|February 14, 2017
Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitroKonstantin A Krychtiuk, Christoph Kaun, Philipp J Hohensinner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 19, 2017
PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically QuiescentPhilipp J Hohensinner, Johanna Baumgartner, Julia B Kral-Pointner, et al.
Basic Research in Cardiology|December 22, 2010
Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γSvitlana Demyanets, Christoph Kaun, Kathrin Rychli, et al.
Critical Care Medicine|October 9, 2015
Mitochondrial DNA and Toll-Like Receptor-9 Are Associated With Mortality in Critically Ill PatientsKonstantin A Krychtiuk, Sarah Ruhittel, Philipp J Hohensinner, et al.
Thrombosis and Haemostasis|March 18, 2006
The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathwaySvitlana Demyanets, Stefan Pfaffenberger, Christoph Kaun, et al.
International Journal of Biological Sciences|March 9, 2026
Metabolic Adaptation of CD8⁺ T Cells Limits the Efficacy of Fatty Acid Oxidation Inhibition in Type 1 DiabetesManuel Salzmann, Laura Boccuni, Patrizia Gibler, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 13, 2022
Staphylococcus aureus extracellular adherence protein (Eap) reduces immune cell phenotype in developing but not in established atherosclerotic lesionsManuel Salzmann, Harald Platzer, Marion Mussbacher, et al.
Blood|June 22, 2019
Differential expression of Plg-R<sub>KT</sub> and its effects on migration of proinflammatory monocyte and macrophage subsetsBarbara Thaler, Nagyung Baik, Philipp J Hohensinner, et al.
Biochemical Pharmacology|May 31, 2021
Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activationPhilipp J Hohensinner, Max Lenz, Patrick Haider, et al.
Haematologica|January 25, 2020
Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesiclesPhilipp J Hohensinner, Julia Mayer, Julia Kichbacher, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Vascular Pharmacology|February 14, 2017
Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitroKonstantin A Krychtiuk, Christoph Kaun, Philipp J Hohensinner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 19, 2017
PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically QuiescentPhilipp J Hohensinner, Johanna Baumgartner, Julia B Kral-Pointner, et al.
Basic Research in Cardiology|December 22, 2010
Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γSvitlana Demyanets, Christoph Kaun, Kathrin Rychli, et al.
Critical Care Medicine|October 9, 2015
Mitochondrial DNA and Toll-Like Receptor-9 Are Associated With Mortality in Critically Ill PatientsKonstantin A Krychtiuk, Sarah Ruhittel, Philipp J Hohensinner, et al.
Thrombosis and Haemostasis|March 18, 2006
The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathwaySvitlana Demyanets, Stefan Pfaffenberger, Christoph Kaun, et al.
International Journal of Biological Sciences|March 9, 2026
Metabolic Adaptation of CD8⁺ T Cells Limits the Efficacy of Fatty Acid Oxidation Inhibition in Type 1 DiabetesManuel Salzmann, Laura Boccuni, Patrizia Gibler, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 13, 2022
Staphylococcus aureus extracellular adherence protein (Eap) reduces immune cell phenotype in developing but not in established atherosclerotic lesionsManuel Salzmann, Harald Platzer, Marion Mussbacher, et al.
Blood|June 22, 2019
Differential expression of Plg-R<sub>KT</sub> and its effects on migration of proinflammatory monocyte and macrophage subsetsBarbara Thaler, Nagyung Baik, Philipp J Hohensinner, et al.
Biochemical Pharmacology|May 31, 2021
Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activationPhilipp J Hohensinner, Max Lenz, Patrick Haider, et al.
Haematologica|January 25, 2020
Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesiclesPhilipp J Hohensinner, Julia Mayer, Julia Kichbacher, et al.
Pageof 5